Literature DB >> 18403432

Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy.

Terumasa Hayashi1, Yoshitsugu Obi, Tomonori Kimura, Ken-Ichiro Iio, Satoru Sumitsuji, Yoshihiro Takeda, Yoshiyuki Nagai, Enyu Imai.   

Abstract

BACKGROUND: The high prevalence of asymptomatic coronary artery stenosis (CAS) in chronic kidney disease (CKD) has emerged as an important predictor of outcome. However, diagnostic tools that can identify asymptomatic CAS have not yet been established. We investigated whether asymptomatic patients at the initiation of renal replacement therapy (RRT) could be screened using cardiac troponin T (cTnT) and atherosclerotic surrogate markers such as ankle-brachial blood pressure index (ABPI) and intima-media thickness (IMT). METHODS AND
RESULTS: Among 142 patients who were about to start RRT, 60 who were asymptomatic underwent coronary evaluation by multi-slice computed tomography (MSCT) and/or coronary angiography (CAG). CAG diagnosed 35 patients (43.8%) as CAS positive and 27 of them had multi-vessel disease. Factors associated with CAS were smoking, elevated cTnT, low ABPI and high IMT. Moreover, the severity of CAS was associated with smoking, cTnT and ABPI. Stepwise logistic regression analyses revealed that cTnT was a powerful predictor of asymptomatic multi-vessel CAS. Receiver operating characteristic analysis documented the usefulness of cTnT as a screening tool with a cut-off point 0.05 ng/ml. The optimal screening tool for multi-vessel CAS was cTnT (sensitivity, 92.6%; 95% CI, 82.7-99.9; specificity, 63.6%; 95% CI, 47.2-80.0).
CONCLUSION: We concluded that cTnT should be measured as part of a strategy for detecting asymptomatic CAS, especially multi-vessel disease in patients with CKD at the start of RRT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403432     DOI: 10.1093/ndt/gfn181

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

1.  Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation.

Authors:  Nicola Kumar; Christopher S R Baker; Kakit Chan; Neill Duncan; Iqbal Malik; Andrew Frankel; Damien R Ashby; Adam McLean; Andrew Palmer; Tom D Cairns; David Taube
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

2.  Effects of nicorandil on the reduction of BNP levels in patients with chronic kidney disease.

Authors:  Tomonori Kimura; Harumi Kitamura; Kazunori Inoue; Noritaka Kawada; Isao Matsui; Yasuyuki Nagasawa; Yoshitsugu Obi; Maki Shinzawa; Yasuhiko Sakata; Takayuki Hamono; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2011-08-23       Impact factor: 2.801

3.  Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.

Authors:  Terumasa Hayashi; Tomonori Kimura; Keiko Yasuda; Koichi Sasaki; Yoshitsugu Obi; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2016-05-13       Impact factor: 2.801

4.  Is cardiac biomarkers and left ventricular function affected by chronic kidney disease?

Authors:  Amir Farhang Zand Parsa; Alireza Abdolahi; Mitra Mahdavimazdeh
Journal:  Indian Heart J       Date:  2012-08-27

5.  Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.

Authors:  Panagiotis Pateinakis; Aikaterini Papagianni
Journal:  Int J Nephrol       Date:  2011-02-06

Review 6.  Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability.

Authors:  Luis D'Marco; Antonio Bellasi; Paolo Raggi
Journal:  Dis Markers       Date:  2015-04-05       Impact factor: 3.434

7.  Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

8.  Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality.

Authors:  Ferruh Artunc; Christian Mueller; Tobias Breidthardt; Raphael Twerenbold; Andreas Peter; Claus Thamer; Peter Weyrich; Hans-Ulrich Haering; Bjoern Friedrich
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

9.  Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.

Authors:  Maurits S Buiten; Mihály K de Bie; Joris I Rotmans; Friedo W Dekker; Marjolijn van Buren; Ton J Rabelink; Christa M Cobbaert; Martin J Schalij; Arnoud van der Laarse; J Wouter Jukema
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

10.  Independent value of cardiac troponin T and left ventricular global longitudinal strain in predicting all-cause mortality among stable hemodialysis patients with preserved left ventricular ejection fraction.

Authors:  Junne-Ming Sung; Chi-Ting Su; Yu-Tzu Chang; Yu-Ru Su; Wei-Chuan Tsai; Saprina P H Wang; Chun-Shin Yang; Liang-Miin Tsai; Jyh-Hong Chen; Yen-Wen Liu
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.